vs

Side-by-side financial comparison of KAMADA LTD (KMDA) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.

PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $47.0M, roughly 1.2× KAMADA LTD). KAMADA LTD runs the higher net margin — 11.3% vs -24.7%, a 36.0% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs -18.3%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs -15.6%).

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.

KMDA vs MYPS — Head-to-Head

Bigger by revenue
MYPS
MYPS
1.2× larger
MYPS
$55.4M
$47.0M
KMDA
Growing faster (revenue YoY)
KMDA
KMDA
+30.9% gap
KMDA
12.6%
-18.3%
MYPS
Higher net margin
KMDA
KMDA
36.0% more per $
KMDA
11.3%
-24.7%
MYPS
Faster 2-yr revenue CAGR
KMDA
KMDA
Annualised
KMDA
12.0%
-15.6%
MYPS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
KMDA
KMDA
MYPS
MYPS
Revenue
$47.0M
$55.4M
Net Profit
$5.3M
$-13.7M
Gross Margin
42.0%
Operating Margin
16.6%
-17.7%
Net Margin
11.3%
-24.7%
Revenue YoY
12.6%
-18.3%
Net Profit YoY
37.1%
38.9%
EPS (diluted)
$0.09
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMDA
KMDA
MYPS
MYPS
Q4 25
$55.4M
Q3 25
$47.0M
$57.6M
Q2 25
$44.8M
$59.3M
Q1 25
$44.0M
$62.7M
Q4 24
$67.8M
Q3 24
$41.7M
$71.2M
Q2 24
$42.5M
$72.6M
Q1 24
$37.7M
$77.8M
Net Profit
KMDA
KMDA
MYPS
MYPS
Q4 25
$-13.7M
Q3 25
$5.3M
$-9.1M
Q2 25
$7.4M
$-2.9M
Q1 25
$4.0M
$-2.9M
Q4 24
$-22.4M
Q3 24
$3.9M
$-3.1M
Q2 24
$4.4M
$-2.6M
Q1 24
$2.4M
$-567.0K
Gross Margin
KMDA
KMDA
MYPS
MYPS
Q4 25
Q3 25
42.0%
Q2 25
42.3%
Q1 25
47.1%
Q4 24
Q3 24
41.3%
Q2 24
44.6%
Q1 24
44.4%
Operating Margin
KMDA
KMDA
MYPS
MYPS
Q4 25
-17.7%
Q3 25
16.6%
-13.6%
Q2 25
15.8%
-5.9%
Q1 25
17.7%
-4.4%
Q4 24
-33.1%
Q3 24
12.7%
-6.7%
Q2 24
13.3%
-5.5%
Q1 24
10.7%
-2.2%
Net Margin
KMDA
KMDA
MYPS
MYPS
Q4 25
-24.7%
Q3 25
11.3%
-15.8%
Q2 25
16.5%
-5.0%
Q1 25
9.0%
-4.6%
Q4 24
-33.1%
Q3 24
9.3%
-4.3%
Q2 24
10.4%
-3.6%
Q1 24
6.3%
-0.7%
EPS (diluted)
KMDA
KMDA
MYPS
MYPS
Q4 25
$-0.12
Q3 25
$0.09
$-0.07
Q2 25
$0.13
$-0.02
Q1 25
$0.07
$-0.02
Q4 24
$-0.18
Q3 24
$0.07
$-0.02
Q2 24
$0.08
$-0.02
Q1 24
$0.04
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMDA
KMDA
MYPS
MYPS
Cash + ST InvestmentsLiquidity on hand
$72.0M
$104.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.2M
$227.9M
Total Assets
$377.2M
$290.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMDA
KMDA
MYPS
MYPS
Q4 25
$104.9M
Q3 25
$72.0M
$106.3M
Q2 25
$66.0M
$112.9M
Q1 25
$76.3M
$107.1M
Q4 24
$109.2M
Q3 24
$72.0M
$105.2M
Q2 24
$56.5M
$106.3M
Q1 24
$48.2M
$127.0M
Stockholders' Equity
KMDA
KMDA
MYPS
MYPS
Q4 25
$227.9M
Q3 25
$265.2M
$238.9M
Q2 25
$260.0M
$245.3M
Q1 25
$252.0M
$244.1M
Q4 24
$244.7M
Q3 24
$255.3M
$265.2M
Q2 24
$251.2M
$263.6M
Q1 24
$251.2M
$288.4M
Total Assets
KMDA
KMDA
MYPS
MYPS
Q4 25
$290.6M
Q3 25
$377.2M
$299.2M
Q2 25
$368.2M
$316.2M
Q1 25
$375.1M
$313.8M
Q4 24
$323.0M
Q3 24
$351.2M
$330.6M
Q2 24
$351.0M
$333.4M
Q1 24
$343.2M
$357.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMDA
KMDA
MYPS
MYPS
Operating Cash FlowLast quarter
$10.4M
$3.7M
Free Cash FlowOCF − Capex
$3.6M
FCF MarginFCF / Revenue
6.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.97×
TTM Free Cash FlowTrailing 4 quarters
$25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMDA
KMDA
MYPS
MYPS
Q4 25
$3.7M
Q3 25
$10.4M
$5.7M
Q2 25
$8.0M
$13.6M
Q1 25
$-513.0K
$3.3M
Q4 24
$11.6M
Q3 24
$22.2M
$14.6M
Q2 24
$14.0M
$14.5M
Q1 24
$1.0M
$5.0M
Free Cash Flow
KMDA
KMDA
MYPS
MYPS
Q4 25
$3.6M
Q3 25
$5.4M
Q2 25
$13.2M
Q1 25
$3.2M
Q4 24
$11.5M
Q3 24
$13.9M
Q2 24
$12.8M
Q1 24
$3.6M
FCF Margin
KMDA
KMDA
MYPS
MYPS
Q4 25
6.5%
Q3 25
9.3%
Q2 25
22.3%
Q1 25
5.1%
Q4 24
16.9%
Q3 24
19.6%
Q2 24
17.6%
Q1 24
4.6%
Capex Intensity
KMDA
KMDA
MYPS
MYPS
Q4 25
0.2%
Q3 25
0.5%
Q2 25
0.7%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.9%
Q2 24
2.4%
Q1 24
1.9%
Cash Conversion
KMDA
KMDA
MYPS
MYPS
Q4 25
Q3 25
1.97×
Q2 25
1.09×
Q1 25
-0.13×
Q4 24
Q3 24
5.75×
Q2 24
3.15×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons